31st Annual Report of Roselabs Finance Limited
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts more than Nifty Microcap 250 and 0.2 pts less than its Other Financial Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Roselabs Finance Limited submitted its 31st Annual Report for the financial year ended March 31, 2025, with the 31st AGM scheduled for September 26, 2025 via video conferencing. Revenue from operations fell sharply to ₹70.91 lakhs from ₹113.65 lakhs in the previous year. The company reported a net loss of ₹29.17 lakhs, widening from a loss of ₹13.20 lakhs in FY 2023-24. The company has no ongoing business and no plans to start any new business, having had its NBFC certificate of registration cancelled in FY 2018-19. No dividend has been recommended.
Shareholders face continued losses, declining revenues, and no clear business roadmap, which is likely to weigh negatively on the stock. The company's lack of operating activity and reliance on its Lodha group affiliation may concern retail investors looking for income or growth.